| Name of the Instrument/Tool | Social Appearance Anxiety Scale (SAAS) |
| First Description |
Hart TA, Flora DB, Palyo SA, et al. Development and examination of the social appearance anxiety scale. Assessment. 2008;15(1):48-59. |
| Year | 2008 |
| Domains | |
| Concept of constructs | Anxiety and depression, Social Function |
| Population/Disease | Generic |
| Originally developed for | --- |
| Other rheumatic diseases where can be applied (only if validated) |
Systemic sclerosis |
| Additional population with no rheumatic diseases |
No |
| Language: Originally published in | English |
| Available in Language | --- |
| REFERENCE IDENTIFICATION | |
| Author/s | Hart TA, Flora DB, Palyo SA, Fresco DM, Holle C, Heimberg RG. |
| Title | Development and examination of the social appearance anxiety scale. |
| Journal | Assessment |
| Year | 2008 |
| Vol | 15 |
| Num | 1 |
| Pages | 48-59 |
| Country | USA |
| Language | English |
| Other references of interest | |
| Link | https://pubmed.ncbi.nlm.nih.gov/29342510/ |
| Brief Description |
Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. |
| Link | https://pubmed.ncbi.nlm.nih.gov/33091259/ |
| Brief Description |
An Update of Outcome Measures in Systemic Sclerosis |
| Instrument/Tool Translations References | |
| No other References. | |
| DEVELOPER CONTACT INFORMATION | |
| Correspondence to | Trevor A Hart |
| trevor.hart@psych .ryerson.ca | |
| Address | York University, USA |
| Website | --- |
| Available | --- |
| Links | --- |
| DESCRIPTION OF THE INSTRUMENT | |
| Type Of Measure | Scale |
| Brief Description |
The scale measures one’s anxiety about being negatively evaluated by others because of one’s overall appearance. It assesses fear and social anxiety in situations in which one’s appearance is evaluated |
| Number of Items | 16 |
| Range | 16-80 |
| Responses options/scale |
No |
| Developed for | Research, Clinical practice |
| PRACTICAL APPLICATION | |
| Method of administration | Self-administered |
| Recommendations to score |
Scoring is done on a Likert-type scale ranging from 1 (not at all) to 5 (extremely). The total score is the sum of all items, with the first item reverse-coded |
| Score Interpretation | A higher SAAS score denotes greater fear |
| Cut-off points | --- |
| Cut-off points applied to | --- |
| Smallest detectable change if described | --- |
| Smallest detectable change applied to | --- |
| Completion time by the patient | - minutes |
| Scoring time by the assessor | - minutes |
| Training to score | Not necessary |
| Strengths | Useful in clinical practice & research |
| Limitations | --- |
| OTHER COMMENTS | |
| Other Comments |
There is a five-item short form (the SAAS-5) developed with responses on the SAAS from 926 people enrolled in the SPIN cohort. SAAS-5 includes items 6, 7, 12, 13, and 14 from the original questionnaire. The shortened version maintained high internal consistency, with a Cronbach’s α of 0.95. The SAAS-5 correlated well (r = 0.97) with the original 16-item SAAS. Similar to the full-length version, the summed scores and the factor scores on the SAAS-5 had a moderate to high positive correlation with the BFNE II (r = 0.66 and 0.68, respectively; P < 0.001). |